Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Monica Grazziutti

Concepts (175)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Transplantation Conditioning
2
2013
89
0.830
Why?
Multiple Myeloma
14
2017
2714
0.710
Why?
Hematopoietic Stem Cell Transplantation
5
2013
532
0.700
Why?
Neutropenia
4
2012
116
0.540
Why?
Enterocolitis, Pseudomembranous
1
2013
26
0.530
Why?
Melphalan
3
2016
176
0.480
Why?
Mannans
5
2011
20
0.430
Why?
Aspergillosis
4
2010
117
0.340
Why?
Stomatitis
1
2006
19
0.330
Why?
Myeloablative Agonists
1
2006
35
0.330
Why?
Reticulocyte Count
1
2006
7
0.320
Why?
Neutrophils
1
2006
163
0.290
Why?
Invasive Pulmonary Aspergillosis
2
2012
13
0.240
Why?
Lymphocyte Activation
2
1998
213
0.210
Why?
Aspergillus
3
2010
50
0.200
Why?
Aspergillus fumigatus
2
1998
63
0.200
Why?
Transplantation, Autologous
4
2014
459
0.200
Why?
Thalidomide
2
2016
406
0.200
Why?
Th1 Cells
1
1997
49
0.180
Why?
Cytokines
2
1998
683
0.170
Why?
Prognosis
8
2017
2077
0.170
Why?
Aged
14
2017
10169
0.160
Why?
Hematologic Neoplasms
2
2008
89
0.160
Why?
Immunoglobulin Light Chains
1
2017
98
0.160
Why?
Neoplasm, Residual
1
2017
173
0.160
Why?
Middle Aged
15
2017
13329
0.150
Why?
Creatinine
2
2012
164
0.150
Why?
Retrospective Studies
8
2014
5788
0.140
Why?
Predictive Value of Tests
3
2007
1051
0.140
Why?
Humans
25
2017
51226
0.140
Why?
Male
16
2017
27647
0.130
Why?
Adult
13
2017
14064
0.130
Why?
Systole
1
2014
79
0.130
Why?
Central Nervous System Neoplasms
1
2013
50
0.130
Why?
Bone Marrow Transplantation
1
2014
165
0.130
Why?
Amyloidosis
1
2014
81
0.130
Why?
Galactose
5
2011
32
0.120
Why?
Female
14
2017
28342
0.120
Why?
Survival Analysis
5
2017
789
0.120
Why?
Metabolic Clearance Rate
1
2012
85
0.120
Why?
Platelet Count
1
2012
77
0.120
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2016
1013
0.110
Why?
Serum
1
2011
40
0.110
Why?
Drug Monitoring
1
2011
90
0.110
Why?
Renal Insufficiency
1
2012
136
0.110
Why?
Mucositis
1
2010
12
0.110
Why?
Paranasal Sinuses
1
2010
24
0.110
Why?
Aged, 80 and over
6
2017
3550
0.110
Why?
Kidney Diseases
2
2017
281
0.100
Why?
Lung
2
2010
488
0.100
Why?
Treatment Outcome
7
2017
5480
0.100
Why?
Kidney
2
2012
763
0.100
Why?
Stem Cell Transplantation
2
2007
194
0.090
Why?
Antigens, Fungal
1
2007
30
0.090
Why?
Lung Diseases, Fungal
1
2007
33
0.090
Why?
Leukocytes, Mononuclear
2
1998
136
0.080
Why?
Acquired Immunodeficiency Syndrome
1
2007
62
0.080
Why?
Lactoperoxidase
1
2006
4
0.080
Why?
Disease-Free Survival
3
2016
522
0.080
Why?
Glucose Oxidase
1
2006
6
0.080
Why?
Incidence
2
2010
1083
0.080
Why?
Professional Misconduct
1
2006
7
0.080
Why?
Muramidase
1
2006
16
0.080
Why?
Ethics, Research
1
2006
40
0.080
Why?
Iron Overload
1
2006
12
0.080
Why?
Drug Combinations
1
2006
131
0.080
Why?
Soft Tissue Infections
1
2005
13
0.080
Why?
Tomography, Emission-Computed
1
2005
71
0.080
Why?
Models, Statistical
1
2007
256
0.080
Why?
Joint Diseases
1
2005
45
0.070
Why?
Models, Theoretical
1
2006
200
0.070
Why?
Regression Analysis
1
2006
475
0.070
Why?
Metaphase
2
2016
57
0.070
Why?
Recovery of Function
1
2006
233
0.070
Why?
Glomerular Filtration Rate
2
2017
136
0.070
Why?
Fluorodeoxyglucose F18
1
2005
201
0.070
Why?
Kinetics
1
2006
724
0.070
Why?
Radiopharmaceuticals
1
2005
253
0.070
Why?
Risk Factors
3
2010
3924
0.070
Why?
Neoplasms
2
2007
1158
0.070
Why?
Severity of Illness Index
1
2006
1077
0.060
Why?
Multivariate Analysis
3
2012
688
0.060
Why?
Dose-Response Relationship, Drug
1
2006
1556
0.060
Why?
Gene Expression Profiling
1
2007
1084
0.060
Why?
Interleukin-2
2
1998
81
0.060
Why?
Plasma Cells
2
2013
225
0.060
Why?
Cohort Studies
1
2006
1485
0.060
Why?
Interferon-gamma
2
1998
196
0.050
Why?
Time Factors
3
2017
3392
0.050
Why?
Bordetella bronchiseptica
1
1998
1
0.050
Why?
Bordetella Infections
1
1998
2
0.050
Why?
Opportunistic Infections
1
1998
59
0.050
Why?
HLA-DR Antigens
1
1997
15
0.050
Why?
Pneumonia, Bacterial
1
1998
26
0.050
Why?
Culture Media, Conditioned
1
1997
52
0.040
Why?
Candida albicans
1
1997
30
0.040
Why?
Interleukin-4
1
1997
49
0.040
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1997
77
0.040
Why?
Lymphocytes
1
1998
175
0.040
Why?
Flow Cytometry
2
1998
583
0.040
Why?
Leukemia
1
1998
75
0.040
Why?
Cell Adhesion Molecules
1
1997
96
0.040
Why?
Coculture Techniques
1
1997
162
0.040
Why?
Kidney Function Tests
1
2017
65
0.040
Why?
Interleukin-10
1
1997
107
0.040
Why?
Mycoses
1
1998
154
0.040
Why?
Dendritic Cells
1
1998
148
0.040
Why?
Cells, Cultured
2
1998
1828
0.040
Why?
Antigens, CD
1
1997
264
0.040
Why?
Tumor Necrosis Factor-alpha
1
1997
430
0.040
Why?
Bone Marrow
1
2017
410
0.040
Why?
Chromosome Aberrations
1
2016
309
0.040
Why?
Biopsy
1
2017
690
0.040
Why?
Myocardium
1
2017
460
0.030
Why?
Cerebrospinal Fluid
1
2013
35
0.030
Why?
Neoplasm Proteins
1
2016
380
0.030
Why?
Ventricular Dysfunction, Left
1
2014
103
0.030
Why?
Magnetic Resonance Imaging
2
2013
1658
0.030
Why?
Gene Expression Regulation, Neoplastic
1
2016
880
0.030
Why?
Risk Assessment
1
2017
1395
0.030
Why?
Recurrence
1
2013
690
0.030
Why?
Immunocompromised Host
1
2012
130
0.030
Why?
C-Reactive Protein
1
2012
160
0.030
Why?
Body Surface Area
1
2010
25
0.030
Why?
Pyrazines
1
2012
205
0.030
Why?
Boronic Acids
1
2012
201
0.030
Why?
Bone Marrow Cells
1
2012
249
0.030
Why?
Neoplasm Staging
1
2013
799
0.030
Why?
Enteritis
1
2010
17
0.030
Why?
Proportional Hazards Models
1
2012
456
0.030
Why?
Databases, Factual
1
2013
685
0.030
Why?
Prospective Studies
1
2016
2395
0.030
Why?
Colitis
1
2010
58
0.030
Why?
Radiography
1
2010
539
0.020
Why?
Disease Progression
1
2012
879
0.020
Why?
Meta-Analysis as Topic
1
2008
38
0.020
Why?
Cytogenetic Analysis
1
2007
78
0.020
Why?
Ethics Committees, Research
1
2006
15
0.020
Why?
Los Angeles
1
2006
25
0.020
Why?
Multicenter Studies as Topic
1
2006
83
0.020
Why?
Peptides, Cyclic
1
2006
41
0.020
Why?
Chromosomes, Human, Pair 1
1
2007
99
0.020
Why?
Echinocandins
1
2006
46
0.020
Why?
Drug Approval
1
2006
46
0.020
Why?
Lipopeptides
1
2006
50
0.020
Why?
Chromosome Deletion
1
2007
147
0.020
Why?
In Situ Hybridization, Fluorescence
1
2007
273
0.020
Why?
Research
1
2006
114
0.020
Why?
Medical Records
1
2005
96
0.020
Why?
Kaplan-Meier Estimate
1
2007
532
0.020
Why?
Dexamethasone
1
2007
399
0.020
Why?
Combined Modality Therapy
1
2007
703
0.020
Why?
Glucocorticoids
1
2007
268
0.020
Why?
Patient Selection
1
2006
293
0.020
Why?
Angiogenesis Inhibitors
1
2006
212
0.020
Why?
Analysis of Variance
1
2006
664
0.020
Why?
Brain
1
2013
1429
0.020
Why?
Antifungal Agents
1
2006
315
0.020
Why?
Adolescent
2
2007
6735
0.010
Why?
Follow-Up Studies
1
2007
2403
0.010
Why?
Anti-Bacterial Agents
1
2005
763
0.010
Why?
Phytohemagglutinins
1
1998
14
0.010
Why?
Bronchoalveolar Lavage Fluid
1
1998
43
0.010
Why?
Leukocyte Transfusion
1
1998
12
0.010
Why?
Colony-Stimulating Factors
1
1998
11
0.010
Why?
Immunomagnetic Separation
1
1998
10
0.010
Why?
Scattering, Radiation
1
1998
28
0.010
Why?
Cell Adhesion
1
1998
186
0.010
Why?
Adjuvants, Immunologic
1
1998
64
0.010
Why?
Light
1
1998
74
0.010
Why?
Reference Values
1
1998
389
0.010
Why?
Acute Disease
1
1998
409
0.010
Why?
Feasibility Studies
1
1998
399
0.010
Why?
United States
1
2006
4931
0.010
Why?
Phenotype
1
1998
814
0.010
Why?
Grazziutti's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description